Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 1999, p. 7388-7398, Vol. 19, No. 11
Laboratory of Immunobiology, Division of
Monoclonal Antibodies, Center for Biologics Evaluation and Research,
Bethesda, Maryland 208921; Istituto di
Morfologia Umana Normale, Università degli Studi "G.
D'Annunzio," 66013 Chieti, Italy2; and
Department of Molecular Genetics, Kansai Medical
University, Moriguchi 570-8506, Japan3
Received 12 March 1999/Returned for modification 3 May
1999/Accepted 23 July 1999
B-cell receptor (BCR)-induced activation of phospholipase C-
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Functional Independence and Interdependence of the Src Homology
Domains of Phospholipase C-
1 in B-Cell Receptor Signal
Transduction

1
(PLC
1) and PLC
2 is crucial for B-cell function. While several signaling molecules have been implicated in PLC
activation, the mechanism coupling PLC
to the BCR remains undefined. The role of
PLC
1 SH2 and SH3 domains at different steps of BCR-induced PLC
1
activation was examined by reconstitution in a PLC
-negative B-cell
line. PLC
1 membrane translocation required a functional SH2
N-terminal [SH2(N)] domain, was decreased by mutation of the SH3
domain, but was unaffected by mutation of the SH2(C) domain. Tyrosine
phosphorylation did not require the SH2(C) or SH3 domains but depended
exclusively on a functional SH2(N) domain, which mediated the
association of PLC
1 with the adapter protein, BLNK. Forcing PLC
1
to the membrane via a myristoylation signal did not bypass the SH2(N)
domain requirement for phosphorylation, indicating that the
phosphorylation mediated by this domain is not due to membrane
anchoring alone. Mutation of the SH2(N) or the SH2(C) domain abrogated
BCR-stimulated phosphoinositide hydrolysis and signaling events, while
mutation of the SH3 domain partially decreased signaling. PLC
1 SH
domains, therefore, have interrelated but distinct roles in BCR-induced
PLC
1 activation.
*
Corresponding author. Mailing address: CBER, 29B/3NN10,
8800 Rockville Pike, Bethesda, MD 20892. Phone: (301) 827-0714. Fax: (301) 827-0852. E-mail: bonvini{at}box-b.nih.gov.
Present address: Department of Biochemistry and Molecular Biology,
Georgetown University, Washington, DC 20057.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|